Microspheres for active embolization
    49.
    发明授权
    Microspheres for active embolization 有权
    活性栓塞微球

    公开(公告)号:US08741351B2

    公开(公告)日:2014-06-03

    申请号:US13371964

    申请日:2012-02-13

    Abstract: The present invention relates to injectable compositions comprising biocompatible, swellable, substantially hydrophilic, non-toxic and substantially spherical polymeric material carriers which are capable of efficiently delivering bioactive therapeutic factor(s) for use in embolization drug therapy. The present invention further relates to methods of embolization gene therapy, particularly for the treatment of angiogenic and non-angiogenic-dependent diseases, using the injectable compositions.

    Abstract translation: 本发明涉及包含生物相容的,可溶胀的,基本上亲水的,无毒的和基本上为球形的聚合物材料载体的可注射组合物,其能够有效地输送用于栓塞药物治疗的生物活性治疗因子。 本发明还涉及使用可注射组合物的栓塞基因治疗方法,特别是用于治疗血管生成和非血管生成依赖性疾病的方法。

    MICROSPHERES FOR ACTIVE EMBOLIZATION
    50.
    发明申请
    MICROSPHERES FOR ACTIVE EMBOLIZATION 有权
    用于主动嵌入的微结构

    公开(公告)号:US20120213831A1

    公开(公告)日:2012-08-23

    申请号:US13462004

    申请日:2012-05-02

    Abstract: The present invention relates to injectable compositions comprising biocompatible, swellable, substantially hydrophilic, non-toxic and substantially spherical polymeric material carriers which are capable of efficiently delivering bioactive therapeutic factor(s) for use in embolization drug therapy. The present invention further relates to methods of embolization gene therapy, particularly for the treatment of angiogenic and non-angiogenic-dependent diseases, using the injectable compositions.

    Abstract translation: 本发明涉及包含生物相容的,可溶胀的,基本上亲水的,无毒的和基本上为球形的聚合物材料载体的可注射组合物,其能够有效地输送用于栓塞药物治疗的生物活性治疗因子。 本发明还涉及使用可注射组合物的栓塞基因治疗方法,特别是用于治疗血管生成和非血管生成依赖性疾病的方法。

Patent Agency Ranking